Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives - PubMed (original) (raw)
Review
. 2010 Aug 23;49(36):6288-308.
doi: 10.1002/anie.200902672.
Affiliations
- PMID: 20648499
- DOI: 10.1002/anie.200902672
Review
Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives
Katrin Knop et al. Angew Chem Int Ed Engl. 2010.
Abstract
Poly(ethylene glycol) (PEG) is the most used polymer and also the gold standard for stealth polymers in the emerging field of polymer-based drug delivery. The properties that account for the overwhelming use of PEG in biomedical applications are outlined in this Review. The first approved PEGylated products have already been on the market for 20 years. A vast amount of clinical experience has since been gained with this polymer--not only benefits, but possible side effects and complications have also been found. The areas that might need consideration and more intensive and careful examination can be divided into the following categories: hypersensitivity, unexpected changes in pharmacokinetic behavior, toxic side products, and an antagonism arising from the easy degradation of the polymer under mechanical stress as a result of its ether structure and its non-biodegradability, as well as the resulting possible accumulation in the body. These possible side effects will be discussed in this Review and alternative polymers will be evaluated.
Similar articles
- Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
Sant S, Poulin S, Hildgen P. Sant S, et al. J Biomed Mater Res A. 2008 Dec 15;87(4):885-95. doi: 10.1002/jbm.a.31800. J Biomed Mater Res A. 2008. PMID: 18228249 - PEG-PLA block copolymer as potential drug carrier: preparation and characterization.
Ben-Shabat S, Kumar N, Domb AJ. Ben-Shabat S, et al. Macromol Biosci. 2006 Dec 8;6(12):1019-25. doi: 10.1002/mabi.200600165. Macromol Biosci. 2006. PMID: 17128420 - Synthesis and characterization of cyclic acetal based degradable hydrogels.
Kaihara S, Matsumura S, Fisher JP. Kaihara S, et al. Eur J Pharm Biopharm. 2008 Jan;68(1):67-73. doi: 10.1016/j.ejpb.2007.05.019. Epub 2007 Jul 13. Eur J Pharm Biopharm. 2008. PMID: 17888640 - Polyethylene glycol (PEG)-Poly(N-isopropylacrylamide) (PNIPAAm) based thermosensitive injectable hydrogels for biomedical applications.
Alexander A, Ajazuddin, Khan J, Saraf S, Saraf S. Alexander A, et al. Eur J Pharm Biopharm. 2014 Nov;88(3):575-85. doi: 10.1016/j.ejpb.2014.07.005. Epub 2014 Aug 1. Eur J Pharm Biopharm. 2014. PMID: 25092423 Review. - Polymer-coated long-circulating microparticulate pharmaceuticals.
Torchilin VP. Torchilin VP. J Microencapsul. 1998 Jan-Feb;15(1):1-19. doi: 10.3109/02652049809006831. J Microencapsul. 1998. PMID: 9463803 Review.
Cited by
- Harnessing Guanidinium and Imidazole Functional Groups: A Dual-Charged Polymer Strategy for Enhanced Gene Delivery.
Mapfumo PP, Reichel LS, Leer K, Egger J, Dzierza A, Peneva K, Fischer D, Traeger A. Mapfumo PP, et al. ACS Macro Lett. 2024 Aug 20;13(8):1000-1007. doi: 10.1021/acsmacrolett.4c00321. Epub 2024 Jul 25. ACS Macro Lett. 2024. PMID: 39052525 Free PMC article. - Determination of _ω_-end functionalities in tailored poly(2-alkyl-2-oxazoline)s by liquid chromatography and mass spectrometry.
Engel N, Dirauf M, Czaplewska JA, Nischang I, Gottschaldt M, Schubert US. Engel N, et al. R Soc Open Sci. 2024 Feb 7;11(2):231008. doi: 10.1098/rsos.231008. eCollection 2024 Feb. R Soc Open Sci. 2024. PMID: 38328565 Free PMC article. - Targeted polymeric therapeutic nanoparticles: design, development and clinical translation.
Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC. Kamaly N, et al. Chem Soc Rev. 2012 Apr 7;41(7):2971-3010. doi: 10.1039/c2cs15344k. Epub 2012 Mar 5. Chem Soc Rev. 2012. PMID: 22388185 Free PMC article. Review. - The PDT activity of free and pegylated pheophorbide a against an amelanotic melanoma transplanted in C57/BL6 mice.
Rapozzi V, Zorzet S, Zacchigna M, Drioli S, Xodo LE. Rapozzi V, et al. Invest New Drugs. 2013 Feb;31(1):192-9. doi: 10.1007/s10637-012-9844-4. Epub 2012 Jun 12. Invest New Drugs. 2013. PMID: 22688292 - Lipid Nanoparticle-Based Delivery System-A Competing Place for mRNA Vaccines.
Zhang X, Li Y, Zhou Z. Zhang X, et al. ACS Omega. 2024 Jan 30;9(6):6219-6234. doi: 10.1021/acsomega.3c08353. eCollection 2024 Feb 13. ACS Omega. 2024. PMID: 38371811 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous